Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib in Premenopausal Women at High Risk for Breast Cancer
NCT00088972Phase 2Terminated
- Sponsor
- SWOG Cancer Research Network
- Start
- Nov 2004
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib oral solution in breast cancer, sponsored by SWOG Cancer Research Network. Started Nov 2004; status: terminated.
02
Drugs
celecoxib oral solution
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00088972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00088972.